It is more important than ever to connect and share ideas. The Law Over Lunch series offers FDLI members the exclusive opportunity to engage in facilitated virtual discussions over lunch on topics of interest to the food and drug law community. This event features unique and co-occurring discussion groups, limited to ten attendees to encourage fruitful conversation. This member-only benefit is a chance to closely learn from, educate, and network with other professionals in the field on new and pertinent topics
Please only sign up for one discussion as they will take place at the same time.
Table Topics and Facilitators
Advertising and Promotion for FDA Regulated Products During COVID-19: Wellness Claims and Consumer Perception
Rachel Gartner, Attorney at Law, Loeb & Loeb
How Alcohol is Regulated: Lessons for Marijuana
Paul E. Pisano, Senior Vice President and General Counsel, National Beer Wholesalers Association
The Court of Appeals Upends the “Skinny” Label Practice – What this Means for Industry
Sara Wexler Koblitz, Associate, Hyman Phelps & McNamara P.C.
RACHEL GARTNER is an attorney at Loeb & Loeb where she focuses her practice on a variety of intellectual property, advertising and emerging media law issues, counseling clients as they navigate complex and evolving environments to bring new concepts, products and technologies to the marketplace, with an eye toward the big picture. Rachel’s experience includes advising clients on advertising claim substantiation, product labeling and packaging, and various other issues relating to advertising, marketing, endorsements, social media and promotions. She also represents clients in challenges brought by administrative bodies such as the U.S. Food and Drug Administration (FDA), U.S. Department of Agriculture (USDA), Federal Trade Commission (FTC), and National Advertising Division (NAD). Additionally, Rachel helps defend her clients against class action lawsuits relating to false or deceptive advertising. Rachel works with clients ranging from start-ups to major corporations spanning a variety of heavily regulated industries, including food, beverage, dietary supplement, cosmetics, and OTC products.
SARA WEXLER KOBLITZ is an associate at Hyman Phelps & McNamara where she advises FDA-regulated clients on a range of issues with a particular focus on Hatch-Waxman patent and exclusivity, biosimilars, and the Orange Book. She helps drug and device manufacturers in various stages of product development and guides clients through the applicable regulatory requirements with respect to applications and submissions, device classification, potential exclusivities, promotional issues, and post-marketing requirements. Ms. Koblitz also counsels cosmetics, food, and dietary supplement clients, with experience regarding genetically-modified foods, medical foods, food labeling, and dietary supplement claims and substantiation. Ms. Koblitz has authored several Citizen Petitions and has worked extensively with litigators and experts in preparation for depositions and trial. She has worked with companies of all sizes, from start-ups to fortune 500 companies. Ms. Koblitz also has experience in export control and other areas of regulatory law. Prior to joining Hyman Phelps & McNamara, Ms. Koblitz practiced at a major intellectual property firm, where she counseled clients on the Hatch-Waxman Act and other areas of FDA regulation. Prior to that she worked on general FDA regulatory matters at an AmLaw 100 firm. While in law school, Ms. Koblitz clerked at the FDA Office of Policy and the Humane Society of the United States.
VIRGINIA BONDURANT PRICE is a partner at McGuireWoods LLP where she handles a broad array of product liability, consumer class action, and commercial litigation matters across the country and in her home state – the Commonwealth of Virginia. She is a member of the firm’s Appeals and Issues practice team and has argued before the Supreme Court of Virginia and the Appellate Court of Illinois, First District, Fourth Division. She regularly represents clients at both the trial level and on appeal in both state court and federal courts. Ginnie has significant experience as outside national coordinating counsel for a fire-safety products company, a role in which she handles a nationwide docket of high-exposure product liability cases. Ginnie routinely advises clients regarding labeling and warnings for consumer products and helps implement strategies with clients regarding litigation, discovery, and litigation avoidance to help companies reduce risk. Additionally, she has extensive experience representing healthcare providers in medical malpractice actions and on regulatory issues, such as complaints made against health care providers’ licenses. Ginnie previously served as an adjunct professor at the University of Richmond School of Law teaching research and writing to first-year students and is a past-president of the John Marshall Inn of Court. Prior to entering private practice, Ginnie served as a law clerk to the Honorable Donald W. Lemons of the Supreme Court of Virginia. While earning her law degree at the University of Richmond, Ginnie was a member of the McNeill Honors Law Society, and she received the Orrell-Brown Award for Clinical Excellence.Labeling During COVID-19: Recalls, Class Actions, and Hand Sanitizer
Virginia Bondurant Price, Partner, McGuireWoods LLP
The Potential Impact of the New Supreme Court Justice on FDA and FDA-regulated Industry
Chad Landmon, Partner, and Alexander Alfano, Associate, Axinn, Veltrop & Harkrider LLP
CHAD LANDMON is a partner at Axinn, Veltrop & Harkrider, LLP, where he Chairs the firm’s FDA and Intellectual Property Practice Groups and regularly works with companies developing drugs, biologics, medical devices, and regenerative medicine and human tissue products. November 5, 2020
12:00-1:00 PM
Registration is open to FDLI members only and is first come, first served.
This is a complimentary virtual event.
Internet Explorer and Microsoft Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.
Please only sign up for one discussion as they will take place at the same time.
For questions, please contact Claire Day.
